Skip to main content

Table 1 Patient characteristics of the test and re-test groups

From: Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients

 

Baseline (T0, pre-operatively)

3 months (T3, post-operatively)

Test-retest (T3 retest)a

Population size (n)

260

182

62

Age (years)

 Mean ± SD

67 ± 10

67 ± 9

67 ± 8

 Median (min-max)

68 (35–88)

68 (38–82)

67 (40–82)

Gender, n (%)

 Women

53 (20%)

37 (20%)

14 (23%)

 Men

207 (80%)

145 (80%)

48 (77%)

Type of surgery, n (%)

 RARC

142 (55%)

99 (54%)

32 (52%)

 ORC

112 (43%)

78 (43%)

30 (48%)

 LRC

6 (2%)

5 (3%)

0 (0%)

Diversion type, n (%)

 Own bladder

233 (90%)

0 (0%)

0 (0%)

 Ileal conduit

11 (4%)

114 (63%)

45 (72%)

 Neobladder

1 (0%)

33 (18%)

11 (18%)

 Other

3 (1%)

31 (17%)

6 (10%)

 Missing

12 (5%)

4 (2%)

0 (0%)

Preoperative chemotherapy (yes), n (%)

38 (15%)

28 (15%)

8 (13%)

Education, n (%)

 Elementary school or less

22 (8%)

17 (9%)

3 (5%)

 Secondary education

94 (36%)

67 (37%)

20 (32%)

 Postsecondary education

116 (45%)

87 (48%)

36 (58%)

 Missing

28 (11%)

11 (6%)

3 (5%)

Living status, n (%)

 Married

177 (68%)

136 (75%)

51 (82%)

 Other

83 (32%)

46 (25%)

11 (18%)

Employment status, n (%)

 Pension

149 (57%)

108 (59%)

36 (58%)

 Salaried employment

61 (24%)

44 (25%)

19 (31%)

 Other

23 (9%)

19 (10%)

4 (6%)

 Missing

27 (10%)

11 (6%)

3 (5%)

  1. aTwo weeks after T3. RARC robot-assisted radical cystectomy, ORC open radical cystectomy, LRC laparoscopic-assisted radical cystectomy